In contrast, our patients with STRA did show enhanced IL-17RA immunoreactivity in submucosa and epithelium as well as increased mRNA expression of IL-17RA and C on stimulation of PBECs with IL-17A when compared with controls without asthma. The gene discussed is IL17RA; the disease is asthma.